SMSPHARMAPharmaceuticals
Sms Pharmaceuticals Ltd — PE Ratio & Valuation Analysis
₹374.85
-5.18%
Current P/E36.26xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E30.0x21.0% above avg
⚠️
14.1% Premium to Industry
SMSPHARMA P/E 36.26x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹8.16 | ₹310 | 38x |
| 2024 | ₹5.89 | ₹239 | 40.6x |
| 2022 | ₹7.35 | ₹83 | 11.3x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Sms Pharmaceuticals Ltd Valuation
Sms Pharmaceuticals Ltd (SMSPHARMA) currently trades at 36.26x earnings. The Pharmaceuticals sector average PE is 31.77x. SMSPHARMA commands a premium, reflecting high growth expectations. Historically, SMSPHARMA has traded at an average PE of 30.0x — it is currently above that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
11.00%
Dividend Yield
0.13%
More on Sms Pharmaceuticals Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.